Glutathione and glutathione analogues; Therapeutic potentials
- 28 November 2012
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1830 (5), 3350-3353
- https://doi.org/10.1016/j.bbagen.2012.11.016
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary diseaseExpert Review of Clinical Pharmacology, 2012
- Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)Journal of Hematology & Oncology, 2012
- Mechanism of Inhibition for N6022, a First-in-Class Drug Targeting S-Nitrosoglutathione ReductaseBiochemistry, 2012
- A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndromeCancer, 2011
- Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsBioorganic & Medicinal Chemistry, 2008
- 3-Morpholinopropyl isothiocyanate is a novel synthetic isothiocyanate that strongly induces the antioxidant response element-dependent Nrf2-mediated detoxifying/antioxidant enzymes in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 2007
- Design, synthesis and properties of novel powerful antioxidants, glutathione analoguesFree Radical Research, 2007
- Glutathione S-transferases as emerging therapeutic targetsEmerging Therapeutic Targets, 2001
- Potential for selective modulation of glutathione in cancer chemotherapyChemico-Biological Interactions, 1998